A new study reveals that women implanted with Bayer AG's Essure permanent contraception device are 10 times more likely to require a second sterilisation procedure, due to complications, than those who opt for laparoscopic sterilisation. These findings cast further doubt on the safety of the Bayer device, which was approved in last month as an alternative to surgical sterilisation. "In some instances, these re-operations are quite major surgeries, including hysterectomies", says Weill Cornell Medicine's Dr Art Sedrakyan.
A new study reveals that women implanted with Bayer AG's Essure permanent contraception device are 10 times more likely to require a second sterilisation procedure, due to complications, than those who opt for laparoscopic sterilisation. These findings cast further doubt on the safety of the Bayer device, which was approved in 2002 as an alternative to surgical sterilisation. "In some instances, these re-operations are quite major surgeries, including hysterectomies", says Weill Cornell Medicine's Dr Art Sedrakyan.